Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm

NCT06195241 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Benign Essential Blepharospasm
Hemifacial Spasm

Interventions

DRUG: DaxibotulinumtoxinA

Sponsor

Montefiore Medical Center

Collaborators

[object Object]